415 related articles for article (PubMed ID: 28467688)
1. Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era.
Cacoub P; Vautier M; Desbois AC; Lafuma A; Saadoun D
Liver Int; 2017 Dec; 37(12):1805-1813. PubMed ID: 28467688
[TBL] [Abstract][Full Text] [Related]
2. Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.
Cacoub P; Si Ahmed SN; Ferfar Y; Pol S; Thabut D; Hezode C; Alric L; Comarmond C; Ragab G; Quartuccio L; Hegazy M; Poynard T; Resche Rigon M; Saadoun D
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):518-526. PubMed ID: 29857143
[TBL] [Abstract][Full Text] [Related]
3. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
[TBL] [Abstract][Full Text] [Related]
4. Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals.
Fayed A; Hegazy MT; Biard L; Vieira M; El Shabony T; Saadoun D; Casato M; Visentini M; Ragab G; Cacoub P
Am J Gastroenterol; 2022 Apr; 117(4):627-636. PubMed ID: 35103020
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
Saadoun D; Pol S; Ferfar Y; Alric L; Hezode C; Si Ahmed SN; de Saint Martin L; Comarmond C; Bouyer AS; Musset L; Poynard T; Resche Rigon M; Cacoub P
Gastroenterology; 2017 Jul; 153(1):49-52.e5. PubMed ID: 28288791
[TBL] [Abstract][Full Text] [Related]
6. Cryoglobulinemia vasculitis: how to handle.
Desbois AC; Comarmond C; Saadoun D; Cacoub P
Curr Opin Rheumatol; 2017 Jul; 29(4):343-347. PubMed ID: 28368978
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands.
van Santen DK; de Vos AS; Matser A; Willemse SB; Lindenburg K; Kretzschmar ME; Prins M; de Wit GA
PLoS One; 2016; 11(10):e0163488. PubMed ID: 27711200
[TBL] [Abstract][Full Text] [Related]
8. Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.
Terrier B; Marie I; Lacraz A; Belenotti P; Bonnet F; Chiche L; Graffin B; Hot A; Kahn JE; Michel C; Quemeneur T; de Saint-Martin L; Hermine O; Léger JM; Mariette X; Senet P; Plaisier E; Cacoub P
J Autoimmun; 2015 Dec; 65():74-81. PubMed ID: 26320984
[TBL] [Abstract][Full Text] [Related]
9. Cryoglobulinemia after the era of chronic hepatitis C infection.
Boleto G; Ghillani-Dalbin P; Musset L; Biard L; Mulier G; Cacoub P; Saadoun D
Semin Arthritis Rheum; 2020 Aug; 50(4):695-700. PubMed ID: 32521323
[TBL] [Abstract][Full Text] [Related]
10. Presentation and outcome of gastrointestinal involvement in hepatitis C virus-related systemic vasculitis: a case-control study from a single-centre cohort of 163 patients.
Terrier B; Saadoun D; Sène D; Scerra S; Musset L; Cacoub P
Gut; 2010 Dec; 59(12):1709-15. PubMed ID: 20841367
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus-induced vasculitis: therapeutic options.
Cacoub P; Terrier B; Saadoun D
Ann Rheum Dis; 2014 Jan; 73(1):24-30. PubMed ID: 23921995
[TBL] [Abstract][Full Text] [Related]
12. Interferon-free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis.
Gragnani L; Cerretelli G; Lorini S; Steidl C; Giovannelli A; Monti M; Petraccia L; Sadalla S; Urraro T; Caini P; Xheka A; Simone A; Arena U; Matucci-Cerinic M; Vergani D; Laffi G; Zignego AL
Aliment Pharmacol Ther; 2018 Aug; 48(4):440-450. PubMed ID: 29952013
[TBL] [Abstract][Full Text] [Related]
13. Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis.
Gragnani L; Lorini S; Martini L; Stasi C; Visentini M; Petraccia L; Marello N; Monti M; Marri S; Madia F; Ricca V; Zignego AL
Clin Rheumatol; 2022 Jan; 41(1):147-157. PubMed ID: 34409558
[TBL] [Abstract][Full Text] [Related]
14. Long-term renal function alterations in hepatitis C patients with SVRs: Impacts of therapies and mixed cryoglobulinemia.
Chang ML; Cheng JS; Chen WT; Hsu CW; Chen KH; Chen YC; Chien RN
J Infect Public Health; 2024 Mar; 17(3):486-494. PubMed ID: 38280352
[TBL] [Abstract][Full Text] [Related]
15. Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: a retrospective cohort study.
Singer AW; Reddy KR; Telep LE; Osinusi AO; Brainard DM; Buti M; Chokkalingam AP
Aliment Pharmacol Ther; 2018 May; 47(9):1278-1287. PubMed ID: 29516535
[TBL] [Abstract][Full Text] [Related]
16. Acute cellular rejection in hepatitis C recipients following liver transplantation in the era of direct-acting antivirals: chronological analysis of the United Network for Organ Sharing database.
Tanaka T; Voigt MD
J Hepatobiliary Pancreat Sci; 2019 Sep; 26(9):393-400. PubMed ID: 31211912
[TBL] [Abstract][Full Text] [Related]
17. Decreasing frequency and improved outcomes of hepatitis C-related liver transplantation in the era of direct-acting antivirals - a retrospective cohort study.
Arora SS; Axley P; Ahmed Z; Satapathy SK; Wong R; Kuo YF; Singal AK
Transpl Int; 2019 Aug; 32(8):854-864. PubMed ID: 30866110
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatitis C with direct-acting antivirals significantly reduces liver-related hospitalizations in patients with cirrhosis.
Hill LA; Delmonte RJ; Andrews B; Richards L; Soto R; Collier S; Kuo A; Cachay E
Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1378-1383. PubMed ID: 29975243
[TBL] [Abstract][Full Text] [Related]
19. Expert opinion on managing chronic HCV in patients with mixed cryoglobulinaemia vasculitis.
Zignego AL; Pawlotsky JM; Bondin M; Cacoub P
Antivir Ther; 2018; 23(Suppl 2):1-9. PubMed ID: 30451151
[TBL] [Abstract][Full Text] [Related]
20. Systemic vasculitis in patients with hepatitis C virus infection with and without detectable mixed cryoglobulinemia.
Terrier B; Sène D; Dechartres A; Saadoun D; Ortonne N; Rouvier P; Musset L; Rigon MR; Maisonobe T; Cacoub P
J Rheumatol; 2011 Jan; 38(1):104-10. PubMed ID: 20952479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
